Turn Therapeutics TTRX
NASDAQ TTRX
$13.33 +0.02 (+0.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Turn Therapeutics (TTRX) Return on Equity [ROE] (2025 - 2026)

Updated

Turn Therapeutics' Return on Equity [ROE] came in at -203.17% for Q2 2026, up 7.84 percentage points from -211.01% a year earlier but down 80.06 percentage points from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Return on Equity [ROE] (2025 - 2026) Analysis & Trends

For FY2025, Turn Therapeutics' Return on Equity [ROE] was -258.54%.

  • The five-year range for quarterly Return on Equity [ROE] is -349.17% (Q3 2025) to -123.11% (Q1 2026).
  • Business Quant data shows TTRX's Return on Equity [ROE] at -123.11% (Q1 2026), -224.79% (Q4 2025) and -349.17% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Turn Therapeutics 397.07 Mn 397.07 Mn - -203.17%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -203.17%
Mar 31, 2026 -123.11%
Dec 31, 2025 -224.79%
Sep 30, 2025 -349.17%
Jun 30, 2025 -211.01%
API Access

Turn Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TTRX&period=max&api_key=YOUR_API_KEY